Moderna Futures Volume Surpasses $100 Million Amid Clinical Data Leak

Huo Xing Cai Jing reports that on October 23, early release of Moderna’s (MRNA) cancer vaccine clinical data triggered significant stock price volatility, prompting a surge in MRNA perpetual contract trading on Hyperliquid. According to TradingBeats, in the three hours following data dissemination around 00:30 Beijing time, MRNA contract trading volume reached approximately 362,000 contracts—9.1 times the volume of the prior three-hour period. The 24-hour rolling trading volume peaked above $104 million; as of publication, the 24-hour trading volume stood at approximately $94.7 million, with the contract priced at $203.33. Prior to the news release, the notional value of open interest for MRNA was approximately $6.84 million. By around 2:00 AM, it surged to $20.31 million—an increase of about 197%—while open interest rose from 30,500 contracts to 108,800 contracts. However, this position expansion was not sustained. As of publication, the notional open interest has declined to approximately $6.27 million, with open interest falling to 30,900 contracts—nearly returning to pre-news levels. Among large traders, one account established a short position of 6,310.91 MRNA contracts during the price decline, currently valued at approximately $1.283 million—the largest identified short position to date. The average entry price was $188.304; however, as the contract price rebounded from its low, this position is now experiencing an unrealized loss of approximately $95,000.